Department of Pharmaceutical Chemistry, School of Pharmacy, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece.
Molecules. 2020 Jul 11;25(14):3173. doi: 10.3390/molecules25143173.
The five membered heterocyclic oxazole group plays an important role in drug discovery. Oxazolones present a wide range of biological activities. In this article the synthesis of 4-substituted-2-phenyloxazol-5(4)-ones from the appropriate substituted aldehydes via an Erlenmeyer-Plochl reaction is reported. Subsequently, the corresponding benzamides were produced via a nucleophilic attack of a secondary amine on the oxazolone ring applying microwave irradiation. The compounds are obtained in good yields up to 94% and their structures were confirmed using IR, H-NMR, C-NMR and LC/MS data. The in vitro anti-lipid peroxidation activity and inhibitory activity against lipoxygenase and trypsin induced proteolysis of the novel derivatives were studied. Inhibition of carrageenin-induced paw edema (CPE) and nociception was also determined for compounds and . Oxazolones and strongly inhibit lipid peroxidation, followed by oxazolones and with an average inhibition of 86.5%. The most potent lipoxygenase inhibitor was the bisbenzamide derivative , with IC 41 μΜ. The benzamides , - and were strong inhibitors of proteolysis. The replacement of the thienyl moiety by a phenyl group does not favor the protection. Compound inhibited nociception higher than . The replacement of thienyl groups by phenyl ring led to reduced biological activity. Docking studies of the most potent LOX inhibitor highlight interactions through allosteric mechanism. All the potent derivatives present good oral bioavailability.
五元杂环噁唑基团在药物发现中起着重要作用。噁唑酮具有广泛的生物活性。本文报道了通过 Erlenmeyer-Plochl 反应,由适当取代的醛合成 4-取代-2-苯并噁唑-5(4)-酮。随后,通过仲胺对噁唑啉环的亲核进攻,应用微波辐射,生成相应的苯甲酰胺。化合物的产率高达 94%。并用 IR、H-NMR、C-NMR 和 LC/MS 数据证实了它们的结构。研究了新型衍生物的体外抗脂质过氧化活性和对脂氧合酶及胰蛋白酶诱导的蛋白水解的抑制活性。还测定了化合物 和 对角叉菜胶诱导的足肿胀(CPE)和疼痛的抑制作用。噁唑酮 和 强烈抑制脂质过氧化,其次是噁唑酮 和 ,平均抑制率为 86.5%。双苯甲酰胺衍生物 是最强的脂氧合酶抑制剂,IC 50 为 41 μΜ。苯甲酰胺 、 和 是强烈的蛋白水解抑制剂。噻吩基被苯基取代不利于保护。化合物 对疼痛的抑制作用高于 。噻吩环被苯基取代导致生物活性降低。通过对接研究,发现最有效的 LOX 抑制剂通过变构机制发生相互作用。所有有效衍生物均具有良好的口服生物利用度。